Nephrocare Health Services Ltd
Listed
NSE & BSE
Mainboard
Live Chart
| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
QIB
|
Over 1.00x
|
9,426,143
49.78% |
49.78%
|
₹433.60 |
|
NII / HNI
|
Over 1.00x
|
2,827,843
14.93% |
14.93%
|
₹130.08 |
|
Retail
|
Over 1.00x
|
6,598,301
34.85% |
34.85%
|
₹303.52 |
|
Employees
|
Awaited |
83,532
0.44% |
0.44%
|
₹3.84 |
| Total | 1.00x | 18,935,819 |
100% | ₹871.05 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| QIB | 9,426,143 | ₹433.60 |
49.78%
|
| NII | 2,827,843 | ₹130.08 |
14.93%
|
| Retail | 6,598,301 | ₹303.52 |
34.85%
|
| Employee | 83,532 | ₹3.84 |
0.44%
|
| Total | 18,935,819 | ₹871.05 |
100.00%
|
| QIB | NII | Retail | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor | Total QIB | Below ₹10L | Above ₹10L | Total NII | |||
| Allocation (shares) | — | — | — | — | — | 2,827,843 | 6,598,301 | 9,426,144 |
| Allotment price (₹) | 460 | 460 | 460 | 460 | 460 | 460 | 460 | 460 |
| No. of applications | — | — | — | — | — | — | — | — |
| No. of shares applied | — | — | — | — | — | — | — | — |
| Amount collected (₹Cr) | — | — | — | — | — | — | ₹303.52 | ₹303.52 |
| Times subscribed | 1 | — | — | — | — | 1 | 1 | 1 |
| Shares allotted | — | — | — | — | — | 2,827,843 | 6,598,301 | 9,426,144 |
| No. of allottees | — | — | — | — | — | — | — | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 64 | ₹29,440 |
| Retail (Max — 13 Lots) | 13 | 416 | ₹191,360 |
| S-HNI (Min — 14 Lots) | 14 | 448 | ₹206,080 |
| B-HNI (Min — 68 Lots) | 68 | 2,176 | ₹1,000,960 |
Nephrocare Health Services Ltd is proposing an IPO on NSE & BSE under the Mainboard category. Total issue: 1,89,35,819 shares (aggregating up to ₹871.05 Cr).
Opens 10 Dec 2025, closes 12 Dec 2025. Listing: 17 Dec 2025. Apply via ASBA or UPI.
| Particulars | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue from Operations | 483.97 | 769.92 | 574.72 |
| EBITDA | 110.31 | 166.64 | 99.66 |
| Profit After Tax (PAT) | 14.23 | 67.10 | 35.13 |
| Net Worth | 716.06 | 594.21 | 423.55 |
| Total Assets | 1193.68 | 996.46 | 806.02 |
| Reserves & Surplus | 704.14 | 578.68 | 408.57 |
| Borrowings | 207.04 | 225.80 | 243.37 |
| EBITDA Margin (%) | 22.05% | — | — |
| PAT Margin (%) | 8.88% | — | — |
Nephrocare Health Services Ltd IPO is subscribed 1.00 times by Dec 12, 2025. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Nephrocare Health Services Ltd IPO retail category is subscribed 1.00 times as of 12 Dec 2025. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 10 Dec 2025 and closes 12 Dec 2025. Min investment: ₹14,720 (1 lot = 32 shares). UPI mandate: 2025-12-12.
The Nephrocare Health Services Ltd IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 18 Dec 2025. Refunds: on 19 Dec 2025.
The Nephrocare Health Services Ltd IPO listing date is 17 Dec 2025, Wednesday. Listed on: NSE & BSE. Issue price: ₹460. Estimated listing: ₹475. GMP: +₹15.
The Nephrocare Health Services Ltd IPO closes on 12 Dec 2025, Friday. UPI mandate: 2025-12-12. Allotment: 18 Dec 2025. Listing: 17 Dec 2025.